MA25679A1 - Derives de monosaccharides utilises comme inhibiteurs d'adhesion de cellules - Google Patents
Derives de monosaccharides utilises comme inhibiteurs d'adhesion de cellulesInfo
- Publication number
- MA25679A1 MA25679A1 MA26265A MA26265A MA25679A1 MA 25679 A1 MA25679 A1 MA 25679A1 MA 26265 A MA26265 A MA 26265A MA 26265 A MA26265 A MA 26265A MA 25679 A1 MA25679 A1 MA 25679A1
- Authority
- MA
- Morocco
- Prior art keywords
- cell adhesion
- adhesion inhibitors
- monosaccharide derivatives
- monosaccharide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22915599A | 1999-01-12 | 1999-01-12 | |
US09/411,357 US6329344B1 (en) | 1998-10-22 | 1999-10-01 | Derivatives of monosaccharides as cell adhesion inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MA25679A1 true MA25679A1 (fr) | 2003-04-01 |
Family
ID=26922990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA26265A MA25679A1 (fr) | 1999-01-12 | 2001-07-12 | Derives de monosaccharides utilises comme inhibiteurs d'adhesion de cellules |
Country Status (29)
Country | Link |
---|---|
US (1) | US6329344B1 (fr) |
EP (1) | EP1144425B1 (fr) |
JP (1) | JP2002534529A (fr) |
CN (1) | CN1254478C (fr) |
AR (1) | AR033939A1 (fr) |
AT (1) | ATE269349T1 (fr) |
AU (1) | AU767948B2 (fr) |
BG (1) | BG105795A (fr) |
BR (1) | BR0007489A (fr) |
CA (1) | CA2359980A1 (fr) |
CO (1) | CO5170511A1 (fr) |
CZ (1) | CZ20012541A3 (fr) |
DE (1) | DE60011568T2 (fr) |
DK (1) | DK1144425T3 (fr) |
ES (1) | ES2223447T3 (fr) |
HK (1) | HK1041006B (fr) |
HR (1) | HRP20010527B1 (fr) |
HU (1) | HUP0200097A3 (fr) |
ID (1) | ID30259A (fr) |
IL (2) | IL144274A0 (fr) |
MA (1) | MA25679A1 (fr) |
MY (1) | MY122723A (fr) |
NZ (2) | NZ512851A (fr) |
PA (1) | PA8489601A1 (fr) |
PT (1) | PT1144425E (fr) |
SK (1) | SK284568B6 (fr) |
TR (1) | TR200102031T2 (fr) |
WO (1) | WO2000042053A1 (fr) |
YU (1) | YU50101A (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152397A (en) * | 2002-10-21 | 2009-02-11 | Hadasit Med Res Service | Compositions and compounds for the treatment of hyperglycemia |
WO2004071515A1 (fr) * | 2003-02-12 | 2004-08-26 | Ranbaxy Laboratories Limited | Preparation de derives de monosaccharide |
AU2003222399A1 (en) * | 2003-05-06 | 2004-11-26 | Ranbaxy Laboratories Limited | Process for the synthesis of base addition salts of 2,3-0-isopropylidene-1-0-substituted-5,6-dideoxy-5-n- (4-(2-hydroxy-2-oxoethyl)-phenylaminocarbonyl) amino-l-gulofuranosides |
CA2526730A1 (fr) | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Derives pyrroliques substitues |
US20060004005A1 (en) * | 2003-09-25 | 2006-01-05 | Sattigeri Viswajanani J | Triazines derivatives as cell adhesion inhibitors |
WO2005092908A1 (fr) * | 2004-03-18 | 2005-10-06 | Ranbaxy Laboratories Limited | Sels d'addition basiques de derives monosaccharides utilises en tant qu'inhibiteurs de l'hyperreactivite des voies aeriennes et des inflammations des voies aeriennes |
WO2005092907A2 (fr) * | 2004-03-26 | 2005-10-06 | Ranbaxy Laboratories Limited | Derives de monosaccharide |
WO2005100373A2 (fr) * | 2004-04-13 | 2005-10-27 | Ranbaxy Laboratories Limited | Derives du monosaccharide |
EP1789428A1 (fr) * | 2004-09-02 | 2007-05-30 | Ranbaxy Laboratories Limited | Derives de monosaccharide |
US20100113371A9 (en) * | 2004-12-22 | 2010-05-06 | Ranbaxy Laboratories Limited Inc. | Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds |
US20090054519A1 (en) * | 2005-07-22 | 2009-02-26 | Abhijit Ray | Derivatives of monosaccharides as 5-lipoxygenase inhibitors |
SG166829A1 (en) | 2005-11-08 | 2010-12-29 | Ranbaxy Lab Ltd | Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
EP1842855A3 (fr) * | 2006-03-29 | 2007-12-05 | Ranbaxy Laboratories Limited | Dérivés de monosaccharide en tant qu'agnets antiinflammaotoires et/ou agents anticancéreux |
US7790689B2 (en) * | 2006-05-30 | 2010-09-07 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
EP1953170A1 (fr) * | 2006-10-03 | 2008-08-06 | Ranbaxy Laboratories Limited | Dérivés de monosaccharide en tant qu'agents anti-inflammatoires |
CN105367612A (zh) * | 2014-08-13 | 2016-03-02 | 中国药科大学 | 龙脷叶由来天然产物丁基2-脱氧-3,6-脱水-β-D-阿拉伯糖呋喃糖苷的全合成方法 |
US20220356150A1 (en) * | 2021-04-30 | 2022-11-10 | Evoco Limited | Biobased diisocyanates, and process for preparation of same |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2715121A (en) | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
US4056322A (en) | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
DE2936240A1 (de) * | 1979-09-07 | 1981-03-26 | Bayer Ag, 51373 Leverkusen | Verfahren zur herstellung bekannter und neuer 6-amino-6-desoxy-2,3-0-isopropyliden-(alpha)-l-sorbofuranose-derivate sowie neue zwischenprodukte des verfahrens |
US4735934A (en) | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
US4996195A (en) | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
US5298494A (en) | 1989-01-09 | 1994-03-29 | Greenwich Pharmaceuticals Incorporated | Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
US5010058A (en) | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
IL100833A0 (en) | 1991-02-20 | 1992-09-06 | Greenwich Pharma | Method for synthesis of ethereally substituted blocked monosaccharides |
US5360792A (en) | 1991-12-20 | 1994-11-01 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
US5360794A (en) | 1992-08-03 | 1994-11-01 | Medicarb Inc. | Disubstituted and deoxy disubstituted derivatives of α-D-mannofuranosides and β-L-gulofuranosides having anti-inflammatory and anti-proliferative activity |
US5367062A (en) | 1992-08-21 | 1994-11-22 | Medicarb Inc. | Disubstituted and deoxydisubstituted derivatives of α-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity |
US5508387A (en) * | 1993-08-04 | 1996-04-16 | Glycomed Incorporated | Selectin binding glycopeptides |
WO1995010296A1 (fr) * | 1993-10-12 | 1995-04-20 | Glycomed Incorporated | Banque de glyco-peptides permettant d'identifier des inhibiteurs d'adherence intercellulaire |
US5637570A (en) | 1995-05-09 | 1997-06-10 | Chemora Pharmochem | Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity |
US5919769A (en) * | 1995-10-26 | 1999-07-06 | Kanebo, Ltd | Fucose derivatives, drugs containing the same as active ingredient, and intermediates for producing the same |
US5824657A (en) | 1997-03-18 | 1998-10-20 | Cubist Pharmaceuticals, Inc. | Aminoacyl sulfamides for the treatment of hyperproliferative disorders |
-
1999
- 1999-10-01 US US09/411,357 patent/US6329344B1/en not_active Expired - Fee Related
-
2000
- 2000-01-10 HU HU0200097A patent/HUP0200097A3/hu unknown
- 2000-01-10 PT PT00900087T patent/PT1144425E/pt unknown
- 2000-01-10 ID IDW00200101521A patent/ID30259A/id unknown
- 2000-01-10 YU YU50101A patent/YU50101A/sh unknown
- 2000-01-10 CZ CZ20012541A patent/CZ20012541A3/cs unknown
- 2000-01-10 AR ARP000100085A patent/AR033939A1/es not_active Application Discontinuation
- 2000-01-10 CN CNB008048428A patent/CN1254478C/zh not_active Expired - Fee Related
- 2000-01-10 SK SK996-2001A patent/SK284568B6/sk unknown
- 2000-01-10 IL IL14427400A patent/IL144274A0/xx not_active IP Right Cessation
- 2000-01-10 DE DE60011568T patent/DE60011568T2/de not_active Expired - Fee Related
- 2000-01-10 WO PCT/IB2000/000021 patent/WO2000042053A1/fr active IP Right Grant
- 2000-01-10 NZ NZ512851A patent/NZ512851A/xx unknown
- 2000-01-10 AT AT00900087T patent/ATE269349T1/de not_active IP Right Cessation
- 2000-01-10 AU AU18860/00A patent/AU767948B2/en not_active Ceased
- 2000-01-10 NZ NZ527482A patent/NZ527482A/en unknown
- 2000-01-10 ES ES00900087T patent/ES2223447T3/es not_active Expired - Lifetime
- 2000-01-10 DK DK00900087T patent/DK1144425T3/da active
- 2000-01-10 JP JP2000593620A patent/JP2002534529A/ja active Pending
- 2000-01-10 TR TR2001/02031T patent/TR200102031T2/xx unknown
- 2000-01-10 CA CA002359980A patent/CA2359980A1/fr not_active Abandoned
- 2000-01-10 EP EP00900087A patent/EP1144425B1/fr not_active Expired - Lifetime
- 2000-01-10 BR BR0007489-6A patent/BR0007489A/pt not_active IP Right Cessation
- 2000-01-11 MY MYPI20000074A patent/MY122723A/en unknown
- 2000-01-12 CO CO00001165A patent/CO5170511A1/es not_active Application Discontinuation
- 2000-01-12 PA PA20008489601A patent/PA8489601A1/es unknown
-
2001
- 2001-07-11 IL IL144274A patent/IL144274A/en unknown
- 2001-07-12 HR HR20010527A patent/HRP20010527B1/xx not_active IP Right Cessation
- 2001-07-12 MA MA26265A patent/MA25679A1/fr unknown
- 2001-08-08 BG BG105795A patent/BG105795A/xx unknown
-
2002
- 2002-04-16 HK HK02102882.5A patent/HK1041006B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA25679A1 (fr) | Derives de monosaccharides utilises comme inhibiteurs d'adhesion de cellules | |
AU4138701A (en) | Partial or full A1 agonists - N6 heterocyclic 5'-thio substituted adenosine derivatives | |
FI951001A0 (fi) | Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina | |
DE69903012D1 (de) | Echokompensation | |
DE69841198D1 (de) | Klebstoffzusammensetzung für chirurgische Zwecke | |
NO20005084L (no) | Heterosykliske glysyl <beta>-alanin derivater som vitronektinantagonister | |
IS5989A (is) | Nýtt kristallað form kalíumsalts (S)-ómeprasóls | |
PT1097127E (pt) | Derivados de diacil-hidrazina como inibidores da integrina | |
AU1283200A (en) | Propanoic acid derivatives as integrin inhibitors | |
PL352296A1 (en) | Crystalline derivatives of 1-methylocarbapeneme | |
AU3561099A (en) | Acylresorcinol derivatives as selective vitronectin receptor inhibitors | |
PT1154988E (pt) | Derivados de mevinolina | |
AU3472600A (en) | Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists | |
MA25342A1 (fr) | 2,3,-o-derives d'isopropylidene de monosaccharides utilises en tant qu'inhibiteurs d'adhesion de cellules. | |
MA26844A1 (fr) | Nouveaux derives de la thiazolidinedione comme agents antidiabetiques | |
AU1817700A (en) | 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 | |
DK1222193T3 (da) | Imidazolderivater som phosphodiesterase VII-inhibitorer | |
PL352281A1 (en) | Substituted derivatives of purine as inhibitors of adhesion of cells | |
PT1088818E (pt) | Derivados de quinolin-4-ilo | |
PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
FI951002A0 (fi) | Sulfatoituja beta-glykolipidijohdannaisia soluadheesioinhibiittoreina | |
HU9904011D0 (en) | Novel salts of dipeptid derivatives | |
DE60021145D1 (de) | Wässrige Beschichtungsmittelzusammensetzung | |
DE60007746D1 (de) | Wässrige beschichtungszusammensetzung für sanitäre dosen | |
AU2028301A (en) | Metal salts of 3-methyl-chromane or thiochromane derivatives |